Trials / Completed
CompletedNCT04372160
Assess Extent of Agreement Between Online 24-hr Dietary Recall and Interviewer-administered 24-hr Dietary Recall on the Same Day for 2 Non-consecutive 2 Days 1 wk Apart to Adults and School Age Children
Cross-sectional Study to Assess the Extent of Agreement Between an Online 24-hr Dietary Recall and an Interviewer-administered 24-hr Dietary Recall on the Same Day for 2 Non-consecutive Days 1 wk Apart to Adults and School Age Children in Order to Compare Energy and Nutrient Intakes Derived From the Two Methods and Conduct User Evaluation of the Online Dietary Assessment Tool
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 204 (actual)
- Sponsor
- PepsiCo Global R&D · Industry
- Sex
- All
- Age
- 7 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Hypothesis: The online 24 hour dietary recall will be comparable to interviewer-administered 24 hour dietary recall considering the limits of agreement in the reporting of energy and macronutrient intake. If the two methods of dietary assessment are comparable (i.e., if greater than 95% of the data plots will lie within the limits of agreement), the online dietary assessment tool could be used in future studies to collect dietary intake data and health data in larger sets of Russian populations, in order to investigate the potential differences in anthropometric risk factors of non-communicable diseases (cancers, diabetes, obesity, hypertension, mortality, etc.) in people with different diet.
Detailed description
Baseline assessments include a demographic questionnaire, including anthropometrics (height, weight), a heath status questionnaire, supplement intake, eating habits, and a food frequency questionnaire, and cardiovascular assessment (blood pressure and heart rate).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dietary assessment | 24-hr dietary recall |
Timeline
- Start date
- 2020-02-19
- Primary completion
- 2020-10-26
- Completion
- 2020-10-26
- First posted
- 2020-05-01
- Last updated
- 2021-03-04
Locations
4 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT04372160. Inclusion in this directory is not an endorsement.